Search results
Pro-Palestinian protesters slam U of M for asking Michigan AG to press charges against students
Michigan Advance· 5 days agoUpdated July 2, 2024 at 11:25 a.m. A coalition of student groups at the University of Michigan say...
Eli Lilly inks another radiopharma deal, gaining option to buy startup
BioPharma Dive· 5 days agoDive Brief: Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics...
Vivos eyes human trials for radiation treatment gel with IDE submission
Clinical Trials Arena· 5 days agoBig pharma has made plays for the space in the past year too, with Eli Lilly, Novartis and Bristol...
St Claire HealthCare officially joins University of Kentucky
Hospital Management· 5 days agoUK president Eli Capilouto noted: "Today, because of the support of policymakers, legislators and so...
Govt panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Business Standard India· 5 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro - ET HealthWorld | Pharma
The Economic Times· 6 days agoHyderabad: An Indian government-approved expert panel has advised the country's drug regulator to...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 6 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
Obesity disease management needs to be revolutionised
Pharmaceutical Technology· 6 days agoObesity has only recently been recognised as a disease as opposed to a behavioural/lifestyle issue....
Atossa Therapeutics updates protocol for breast cancer treatment trial
Clinical Trials Arena· 6 days agoAtossa Therapeutics has announced a protocol amendment in its ongoing clinical trial of...
Sanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt says - ET HealthWorld | Pharma
The Economic Times· 6 days agoThe paper cited German government sources as saying Sanofi changed course after initial...